Abstract
Hydrogels have emerged as an unique and potential transporters for the target drug delivery systems in cancer therapy. Cancer is a terrible disease extracting toll on human health across the world probably due to several drawbacks of the conventional cancer treatments. However, hydrogels facilitate the modern and improved prospects for the treatment of cancer with minimum cytotoxic effects to the healthier cells or tissues. Besides, the easy tailoring associated with the structural features and high biocompatibility of hydrogels have attracted enough attention and offer them as a strong tool for the development of nanomedicine. This review is devoted to update the current studies related to hydrogels and their applications as vectors for cancer chemotherapy.
Keywords: Biocompatibility, cancer chemotherapy, drug delivery, hydrogels, nanomedicine.
Current Cancer Therapy Reviews
Title:Potentials of Hydrogels in Cancer Therapy
Volume: 10 Issue: 3
Author(s): Prem Prakash Sharma, Ravindra Kumar, Anil K Singh, Brajendra K Singh, Ajay Kumar and Brijesh Rathi
Affiliation:
Keywords: Biocompatibility, cancer chemotherapy, drug delivery, hydrogels, nanomedicine.
Abstract: Hydrogels have emerged as an unique and potential transporters for the target drug delivery systems in cancer therapy. Cancer is a terrible disease extracting toll on human health across the world probably due to several drawbacks of the conventional cancer treatments. However, hydrogels facilitate the modern and improved prospects for the treatment of cancer with minimum cytotoxic effects to the healthier cells or tissues. Besides, the easy tailoring associated with the structural features and high biocompatibility of hydrogels have attracted enough attention and offer them as a strong tool for the development of nanomedicine. This review is devoted to update the current studies related to hydrogels and their applications as vectors for cancer chemotherapy.
Export Options
About this article
Cite this article as:
Prakash Sharma Prem, Kumar Ravindra, K Singh Anil, K Singh Brajendra, Kumar Ajay and Rathi Brijesh, Potentials of Hydrogels in Cancer Therapy, Current Cancer Therapy Reviews 2014; 10 (3) . https://dx.doi.org/10.2174/157339471003150212111617
DOI https://dx.doi.org/10.2174/157339471003150212111617 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cannabinoids, Immune System and Cytokine Network
Current Pharmaceutical Design Zinc Dependent Histone Deacetylase Inhibitors in Cancer Therapeutics: Recent Update
Current Medicinal Chemistry Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design A Review on Extraction, Synthesis and Anticancer Activity of Betulinic Acid
Current Bioactive Compounds Current Concepts for the Combined Treatment Modality of Ionizing Radiation with Anticancer Agents
Current Pharmaceutical Design Vasotrophic Regulation of Age-Dependent Hypoxic Cerebrovascular Remodeling
Current Vascular Pharmacology Peroxisome Proliferator-Activated Receptors: Role of Isoform Gamma in the Antineoplastic Effect of Iodine in Mammary Cancer
Current Cancer Drug Targets EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
Current Cancer Drug Targets Fluorescein Fluorescence Use in the Management of Intracranial Neoplastic and Vascular Lesions: A Review and Report of a New Technique
Current Drug Discovery Technologies Progress in Drug Treatment of Cerebral Edema
Mini-Reviews in Medicinal Chemistry The Engaged Role of Tumor Microenvironment in Cancer Metabolism: Focusing on Cancer-Associated Fibroblast and Exosome Mediators
Anti-Cancer Agents in Medicinal Chemistry Signal Transduction Therapy Targeting Apoptosis Pathways in Cancers
Current Signal Transduction Therapy Characterization of Molecular and Functional Alterations of Tumor Endothelial Cells to Design Anti-Angiogenic Strategies
Current Vascular Pharmacology Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry
Current Neuropharmacology Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders
CNS & Neurological Disorders - Drug Targets Subject Index to Volume 4
Current Medicinal Chemistry - Anti-Cancer Agents Mechanisms of ERK1/2 Regulation by Seven-Transmembrane-Domain Receptors
Current Pharmaceutical Design Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for Diagnosis and Therapy of Gliomas
Current Pharmaceutical Design NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Gankyrin Oncoprotein: Structure, Function, and Involvement in Cancer
Current Chemical Biology